Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Malignant Melanoma of Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNo Longer AvailableNCT01005537
What this trial is testing

Cyclophosphamide, Autologous Lymphocytes, and Aldesleukin in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00062036
What this trial is testing

Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Institutes of Health Clinical Center (CC) 33
Testing effectiveness (Phase 2)Study completedNCT03743766
What this trial is testing

Nivolumab, BMS-936558 in Combination With Relatlimab, BMS-986016 in Patients With Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic Setting

Who this might be right for
Melanoma
John Kirkwood 43
Testing effectiveness (Phase 2)Ended earlyNCT01026051
What this trial is testing

Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma

Who this might be right for
Stage III MelanomaStage IV Melanoma
Mannkind Corporation 5
Testing effectiveness (Phase 2)UnknownNCT05907512
What this trial is testing

Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8
Fudan University 43
Testing effectiveness (Phase 2)Study completedNCT00794235
What this trial is testing

Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine

Who this might be right for
Melanoma Stage III or IVNo Prior Chemotherapy
University of Zurich 12
Testing effectiveness (Phase 2)Study completedNCT00002733
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
Hoag Memorial Hospital Presbyterian 30
Early research (Phase 1)Study completedNCT00017121
What this trial is testing

Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung

Who this might be right for
Melanoma (Skin)Metastatic Cancer
Alliance for Clinical Trials in Oncology 40
Early research (Phase 1)Ended earlyNCT01557114
What this trial is testing

Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma

Who this might be right for
Malignant Melanoma
Gustave Roussy, Cancer Campus, Grand Paris 19
Early research (Phase 1)Study completedNCT00470015
What this trial is testing

Vaccine Therapy and GM-CSF With or Without Low-Dose Aldesleukin in Treating Patients With Stage II, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Mayo Clinic 20
Testing effectiveness (Phase 2)Ended earlyNCT05234437
What this trial is testing

A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma

Who this might be right for
Melanoma
QBiotics Group Limited 1
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT00256230
What this trial is testing

Disulfiram in Patients With Metastatic Melanoma

Who this might be right for
Stage IV Melanoma
John P. Fruehauf 7
Testing effectiveness (Phase 2)UnknownNCT03166397
What this trial is testing

Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients

Who this might be right for
Malignant Melanoma Stage IV
Sheba Medical Center 30
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Testing effectiveness (Phase 2)Study completedNCT00042783
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
SWOG Cancer Research Network
Not applicableStudy completedNCT03199846
What this trial is testing

Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States

Who this might be right for
Melanoma
Bristol-Myers Squibb 650
Early research (Phase 1)Study completedNCT00089362
What this trial is testing

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)UnknownNCT02076646
What this trial is testing

A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma Stage IV
Philogen S.p.A. 96
Early research (Phase 1)UnknownNCT05068453
What this trial is testing

Study of Oncolytic Virus in Combination With HX-008 and Radiotherapy in Melanoma Patients With Liver Metastasis

Who this might be right for
Melanoma Stage IV
Peking University Cancer Hospital & Institute 15
Next Page